ASCO 2021 Highlights on OlympiA Trial for (g)BRCA1/2-m & High-Risk HER2- eBC: Adjuvant Olaparib After (Neo)adjuvant Chemo

254 views
July 9, 2021
Comments 0
Login to view comments. Click here to Login